References
- Silverberg E, Lubera JA. Cancer statistics, 1989. CA 1989: 39(1): 3–20
- Jewett HJ. Significance of the palpable prostate nodule. JAMA 1956: 161 (39): 838–41
- Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer 1980: 45(7 Suppl): 1906–11
- Seamonds B, Yang N, Anderson K, et al. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urolog) 1986: 28(6): 472–9
- Drago JR, Badalament RA, Wientjes MG, et al. The relative value of prostatic-specific antigen and prostatic acid phosphatase in the diagnosis and management of adenocarcinoma of the prostate: the Ohio State University experience. Urology 1989: 34(4): 187–92
- Golimbu M, Morales R Al-Askari S, et al. CAT scanning in staging of prostatic cancer. Urology 1981: 18(3): 305–8
- Nesbitt JA, Drago JR, Badalament RA. Transrectal ultrasonography: early experience with use as prostate cancer detection tool. Urology 1989: 34(3): 120–2
- Drago JR, Nesbitt JA, Badalament RA. Use of transrectal ultrasound in detection of prostatic carcinoma: a preliminary report. J Surg Oncol 1989: 41(4): 274–7
- Cooner WH, Eggers GW, Lichtenstein P. Prostate cancer: new hope for early diagnosis. Ala Med 1987: 56(12): 13–6
- Egender G, Furtschegger A, Schachtaer W, et al. Transrectal ultrasonography in diagnosis and staging of prostatic cancer. World J Uroll 1986: 4(2): 163–70
- Lee F, Littrup PJ, Torp-Pedersen ST, et al. Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 1988: 168(2): 389–94
- Mettlin C. National prostate cancer detection program. Presented before Third International Symposium on Transrectal Ultrasound. Chicago: 1988 Sep 23–4
- Wang MC, Valenzuela LA, Murphy GR et al. Purification of a human prostate specific antigen. Invest Urol 1979: 17(2): 159–63
- Stamey TA, Kabalin JN, McNeal JE, et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989: 141(5): 1076–83
- Frankfurt OS, Chin JL, Englander LS, et al. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Cancer Res 1985: 45(3): 1418–23
- Winkler HZ, Rainwater LM, Myers RP, et al. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 1988: 63(2): 103–12
- Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer 1973: 32(4): 1113–8
- Gibbons RP, Correa RJ Jr, Brannen GF, et al. Total prostatectomy for localized prostatic cancer. J Urol 1984: 131(1): 73–6
- Bagshaw MA. Radiation therapy for cancer of the prostate. In: Skinner DG, Lieskovsky G, eds. Diagnosis and management of genitourinary cancer. Philadelphia: WB Saunders, 1988: 417–45
- Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983: 4(5): 473–85
- Reiner WG, Walsh PC. An anatomic approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic prostatectomy. J Urol 1985: 143: 81–3
- Drago JR, Nesbitt JA, Badalament RA. Radical nerve-sparing prostatectomy: the first 30 patients treated with epidural anesthesia. J Surg Oncol 1989: 40(3): 182–4
- The Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984: 311 (20): 1281–6
- Crawford ED, Eisenbeiger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989: 321(7): 419–24 [erratum, N Engl J Med 1989: 321(20): 1420]
- Rohner TJ Jr. Choosing hormonal therapy treatment for patients with metastatic prostatic cancer. In: Wise HA, Klein LA, eds. Practical points in urologic practice. Philadelphia: Lea & Febiger, 1990: 1–4